NCT02210325View on ClinicalTrials.gov

Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea

PHASE3CompletedINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

February 22, 2017

Study Completion Date

February 22, 2017

Conditions
Uncomplicated Urogenital Gonorrhea
Interventions
DRUG

solithromycin

DRUG

ceftriaxone

DRUG

azithromycin

Trial Locations (5)

2000

Sydney

3053

Melbourne

21205

Baltimore

43614

Toledo

44109

Cleveland

Sponsors
All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Melinta Therapeutics, Inc.

INDUSTRY